Humanizing the Protease-Activated Receptor (PAR) Expression Profile in Mouse Platelets by Knocking PAR1 into the Par3 Locus Reveals PAR1 Expression Is Not Tolerated in Mouse Platelets-Reference-Cited by-同舟云学术

Humanizing the Protease-Activated Receptor (PAR) Expression Profile in Mouse Platelets by Knocking PAR1 into the Par3 Locus Reveals PAR1 Expression Is Not Tolerated in Mouse Platelets

Published:2016-10-27 Issue:10 Volume:11 Page:e0165565
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

French Shauna L.,Paramitha Antonia C.,Moon Mitchell J.,Dickins Ross A.,Hamilton Justin R.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference30 articles.

1. Thrombin signalling and protease-activated receptors;SR Coughlin,2000

2. Approval of the first protease-activated receptor antagonist: Rationale, development, significance, and considerations of a novel anti-platelet agent;SL French,2015

3. Protease receptor antagonism to target blood platelet therapies;M Holinstat,2016

4. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation;T-KH Vu,1991

5. A dual thrombin receptor system for platelet activation;ML Kahn,1998

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modelling arterial thrombus formation in vitro;Current Opinion in Hematology;2023-11-03

2. The predominant PAR4 variant in individuals of African ancestry worsens murine and human stroke outcomes;Journal of Clinical Investigation;2023-09-15

3. Species Differences in Platelet Protease-Activated Receptors;International Journal of Molecular Sciences;2023-05-05

4. Human and mouse PAR4 are functionally distinct receptors: Studies in novel humanized mice;Journal of Thrombosis and Haemostasis;2022-05

5. Protease‐activated receptor antagonists prevent thrombosis when dual antiplatelet therapy is insufficient in an occlusive thrombosis microfluidic model;Research and Practice in Thrombosis and Haemostasis;2022-03